(2S)-2-azaniumylpropanoate

Details

Top
Internal ID eb34522e-38da-4bb5-a38b-539efc34b26f
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Alanine and derivatives
IUPAC Name (2S)-2-azaniumylpropanoate
SMILES (Canonical) CC(C(=O)[O-])[NH3+]
SMILES (Isomeric) C[C@@H](C(=O)[O-])[NH3+]
InChI InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1
InChI Key QNAYBMKLOCPYGJ-REOHCLBHSA-N
Popularity 24,848 references in papers

Physical and Chemical Properties

Top
Molecular Formula C3H7NO2
Molecular Weight 89.09 g/mol
Exact Mass 89.047678466 g/mol
Topological Polar Surface Area (TPSA) 67.80 Ų
XlogP -2.40
Atomic LogP (AlogP) -2.63
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 1

Synonyms

Top
18875-37-1
[3H]alanine
[14C]alanine
[3H]-alanine
[14C]-alanine
L-alanine zwitterion
3ip5
(2S)-2-ammoniopropanoate
D09ADQ
D0X1RG
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of (2S)-2-azaniumylpropanoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9866 98.66%
Caco-2 - 0.9372 93.72%
Blood Brain Barrier + 0.8250 82.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Lysosomes 0.4898 48.98%
OATP2B1 inhibitior - 0.8603 86.03%
OATP1B1 inhibitior + 0.9607 96.07%
OATP1B3 inhibitior + 0.9618 96.18%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9435 94.35%
P-glycoprotein inhibitior - 0.9906 99.06%
P-glycoprotein substrate - 0.9845 98.45%
CYP3A4 substrate - 0.7803 78.03%
CYP2C9 substrate - 0.6062 60.62%
CYP2D6 substrate - 0.8524 85.24%
CYP3A4 inhibition - 0.9803 98.03%
CYP2C9 inhibition - 0.9682 96.82%
CYP2C19 inhibition - 0.9664 96.64%
CYP2D6 inhibition - 0.9369 93.69%
CYP1A2 inhibition - 0.8944 89.44%
CYP2C8 inhibition - 0.9978 99.78%
CYP inhibitory promiscuity - 0.9798 97.98%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) + 0.5374 53.74%
Carcinogenicity (trinary) Non-required 0.6701 67.01%
Eye corrosion + 0.8697 86.97%
Eye irritation + 0.6882 68.82%
Skin irritation + 0.7484 74.84%
Skin corrosion + 0.8579 85.79%
Ames mutagenesis - 0.7900 79.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8751 87.51%
Micronuclear + 0.6400 64.00%
Hepatotoxicity + 0.8750 87.50%
skin sensitisation - 0.9845 98.45%
Respiratory toxicity - 0.9444 94.44%
Reproductive toxicity + 0.5333 53.33%
Mitochondrial toxicity - 0.8125 81.25%
Nephrotoxicity + 0.6635 66.35%
Acute Oral Toxicity (c) III 0.7831 78.31%
Estrogen receptor binding - 0.9583 95.83%
Androgen receptor binding - 0.9477 94.77%
Thyroid receptor binding - 0.8888 88.88%
Glucocorticoid receptor binding - 0.9186 91.86%
Aromatase binding - 0.8980 89.80%
PPAR gamma - 0.8884 88.84%
Honey bee toxicity - 0.9388 93.88%
Biodegradation + 0.7500 75.00%
Crustacea aquatic toxicity - 0.8700 87.00%
Fish aquatic toxicity - 0.8272 82.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1075138 Q9NUW8 Tyrosyl-DNA phosphodiesterase 1 2511.9 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.58% 96.09%
CHEMBL4040 P28482 MAP kinase ERK2 87.09% 83.82%
CHEMBL2581 P07339 Cathepsin D 84.69% 98.95%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 80.80% 100.00%

Cross-Links

Top
PubChem 7311724
NPASS NPC272614
ChEMBL CHEMBL279597